Irvine-Gass syndrome: cystoid macular edema reaction to first time anti-VEGF therapy

Session Details

Session Title: Presented Poster Session: Cataract Surgery Complications and Management IV

Session Date/Time: Sunday 06/09/2015 | 15:00-16:30

Paper Time: 16:20

Venue: Poster Village: Pod 1

First Author: : Ē.Elksnis LATVIA

Co Author(s): :    G. Laganovska              

Abstract Details

Purpose:

This study was made to find out Irvine Gass syndrome - cystoid macular edema reaction to first time anti-VEGF treatment and to compere the results with world ophthalmology literature data.

Setting:

In a retrospective study were analyzed clinicaly significant CME patients after cataract surgery in year 2014 in Pauls Stradins clinical university hospitl.

Methods:

Data as central macular thickness with OCT, visual acuity before anti VEGF therapy and 1 week after 1st injection, time of onset of the complaints were analyzed. The results were compered with the world ophtalmology literature.

Results:

Together 7 patients (8 eyes) were included in the study with clinicaly significant CME. 2 male, 5 female patients. Avarage age 75.41 ± 0.41. the avarage time period after cataract surgery to significant complainment 5 weeks. The avarage macular thickness before anit-VEGF therapy 427.37 µm, after – 325.23 µm. The avarege macular thickness decresed by 102.14 µm (p=0.1). Best corrected visual acuity incresed by 2.5 lines. (the avarage Visus before injection = 0.38; Visus after injection = 0.63.)

Conclusions:

Even if the results are statistically unproved, the macular thickness changes after injection, visual acuity, time of onset of the complaints are similar as in the world ophthalmology literature.

Financial Interest:

NONE